Posted inCardiology Diabetes & Endocrinology news
Chronic Inflammation via suPAR: The Missing Link Between Diabetes and Cardiovascular Mortality
A landmark study in Diabetes Care reveals that soluble urokinase plasminogen activator receptor (suPAR) mediates over half of the increased risk for adverse cardiovascular outcomes in patients with diabetes and coronary artery disease, surpassing traditional inflammatory markers like hs-CRP.